Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study

Murali Ramaswamy, Praveen Mannam, Robert Comer, Emily Sinclair, D. Brent McQuaid, Monica L. Schmidt
doi: https://doi.org/10.1101/2020.05.14.20099234

Article Information

doi 
https://doi.org/10.1101/2020.05.14.20099234
History 
  • May 19, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Murali Ramaswamy, MD1,*,
  2. Praveen Mannam, MD2,
  3. Robert Comer, MD3,
  4. Emily Sinclair, PharmD4,
  5. D. Brent McQuaid, MD2 and
  6. Monica L. Schmidt, MPH, PhD5
  1. 1Division of Critical Care & Pulmonary Medicine, LeBauer Healthcare at Cone Health, Greensboro NC & CEO Pulmonix, LLC, Greensboro, NC
  2. 2Division of Critical Care & Pulmonary Medicine, LeBauer Healthcare at Cone Health, Greensboro NC
  3. 3Division of Infectious Diseases Medicine, Cone Health, Greensboro NC
  4. 4Division of Antimicrobial Stewardship, Clinical Pharmacy, Cone Health, Greensboro NC
  5. 5Enterprise Analytics, Cone Health, Greensboro NC
  1. ↵*Corresponding author; email: murali.ramaswamy{at}pulmonix.com

  1. No funding was received for this work

Back to top
Posted May 19, 2020.
Download PDF
Data/Code
Email
Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study
Murali Ramaswamy, Praveen Mannam, Robert Comer, Emily Sinclair, D. Brent McQuaid, Monica L. Schmidt
medRxiv 2020.05.14.20099234; doi: https://doi.org/10.1101/2020.05.14.20099234
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area